Browsing: Therapeutics

Polaryx Therapeutics Inc. (NASDAQ:PLYX) shares are up on Tuesday as the company has made significant strides in advancing its clinical programs.The positive movement follows the announcement…

Vamil DivanGuggenheim Securities, LLC, Research Division Thanks so much, everyone, again, for joining us for the second day of our Guggenheim Emerging Outlook: Biotech Summit. I’m…

FollowPlay Earnings CallPlay Earnings Call Halozyme Therapeutics, Inc. (HALO) Q4 2025 Sales/Trading Call January 28, 2026 8:30 AM EST Company Participants Tram Bui – Head of…

FollowPlay Earnings CallPlay Earnings Call Plus Therapeutics, Inc. (PSTV) Discusses Business Update, REYOBIQ Clinical Program Progress, and Recent Financial Offering January 22, 2026 9:00 AM EST…

This article was written byFollowI have my PhD in biochemistry and have worked for years analyzing clinical trials and biotech companies. It is my passion to…

Susmita Roy Good morning, everyone. My name is Susmita Roy. I’m an associate on the JPMorgan Healthcare Investment Banking team. On behalf of JPMorgan, thank you…

Unknown Analyst Welcome, everyone. My name is [ Tai Pavumi ], and I’m welcoming you to the 44th JPMorgan Healthcare Conference. Our next presenting company is…

Lut Ming ChengJPMorgan Chase & Co, Research Division Good afternoon, everyone. Thanks for joining us for another session at the 44th JPMorgan Healthcare Conference. I’m Brian…

Lut Ming ChengJPMorgan Chase & Co, Research Division Good morning, everyone. Thanks for joining us for another session at the 44th JPMorgan Healthcare Conference. I’m Brian…

Jessica FyeJPMorgan Chase & Co, Research Division Great. Good afternoon, everyone. My name is Jess Fye, large-cap biotech analyst at JPMorgan, and we’re continuing the 44th…